Himadri Speciality Chemical Ltd has made a regulatory disclosure regarding the allotment of equity shares under its Employee Stock Option Plan (ESOP).
The Nomination and Remuneration Committee of the Company, at its meeting held on August 10, 2026, allotted 13,576 equity shares of Re. 1 each to eligible employees upon exercise of options under the "Himadri Employee Stock Option Plan 2016".
The allotment details are as follows:
- Grant Type: Grant-II
- Number of Shares: 13,576
- Face Value per Share: Re. 1
- Exercise Price per Share: ₹140 (including premium)
- Premium per Share: ₹139
- Total Issue Price: ₹1,900,640 (13,576 shares × ₹140)
Consequently, the company's issued and paid-up share capital has increased to ₹50,45,74,175 consisting of 50,45,74,175 equity shares of Re. 1 each.
The distinctive numbers of the shares allotted range from 50,45,60,600 to 50,45,74,175. The shares have been issued in demat form with ISIN INE019C01026 and rank pari-passu with existing shares. There are no lock-in restrictions on these shares.
The company has provided a statement pursuant to Regulation 10(c) of the SEBI (Share based Employee Benefits and Sweat Equity) Regulations, 2021 in Annexure A, which includes details of the stock exchange approvals:
- BSE Limited: In Principle Approval No. DCS/IPO/JR/ESOP-IP/3354/2018-19 dated November 30, 2018
- National Stock Exchange of India Limited: In Principle Approval No. NSE/LIST/18893 dated December 11, 2018
The disclosure has been filed with both BSE Limited and National Stock Exchange of India Limited pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The document was signed by Monika Saraswat, ACS: 29322, who serves as Company Secretary & Compliance Officer of Himadri Speciality Chemical Ltd, with digital signature timestamped August 10, 2026 at 17:54:32 +05:30.